Titan Pharmaceuticals IncNASDAQ:TTNP
- LAST PRICE5.3500
- TODAY'S CHANGE (%)0.1099 (2.0973%)
- Bid / Lots5.2800/ 1
- Ask / Lots5.4000/ 10
- Open / Previous Close5.4600 / 5.2401
- Day Range
- 52 Week Range
- Volume9,620
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TTNP |
|---|---|---|
| 09:32 ET | 358 | 5.46 |
| 09:43 ET | 2290 | 5.2499 |
| 09:45 ET | 3513 | 5.21 |
| 12:02 ET | 634 | 5.25 |
| 12:41 ET | 600 | 5.31 |
| 12:52 ET | 200 | 5.35 |
Sep 10, 2024
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, TTNP, FRZA on Behalf of Shareholders, from 8:31AM ET on Tuesday Sep 10, 2024 by Dow Jones
8:31AM ET on Tuesday Sep 10, 2024 by Dow Jones
Sep 9, 2024
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iteris, Inc. (Nasdaq - ITI), Forza X1, Inc. (Nasdaq - FRZA), Titan Pharmaceuticals, Inc. (Nasdaq - TTNP), Gatos Silver, Inc. (NYSE - GATO), from 4:55PM ET on Monday Sep 09, 2024 by Dow Jones
4:55PM ET on Monday Sep 09, 2024 by Dow JonesSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, FRZA, TTNP on Behalf of Shareholders, from 12:23PM ET on Monday Sep 09, 2024 by Dow Jones
12:23PM ET on Monday Sep 09, 2024 by Dow Jones
Sep 5, 2024
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, CFB, TTNP, DFS on Behalf of Shareholders, from 5:02PM ET on Thursday Sep 05, 2024 by Dow Jones
5:02PM ET on Thursday Sep 05, 2024 by Dow JonesSHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Titan Pharmaceuticals, Inc. -- TTNP, from 4:32PM ET on Thursday Sep 05, 2024 by Dow Jones
4:32PM ET on Thursday Sep 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Titan Pharmaceuticals Inc | 4.8M | -0.8x | --- |
CannaPharmaRx Inc | 4.6M | -1.4x | --- |
AgriFORCE Growing Systems Ltd | 4.5M | 0.0x | --- |
GT Biopharma Inc | 4.8M | -0.3x | --- |
Sonnet Biotherapeutics Holdings Inc | 3.6M | -0.2x | --- |
Hoth Therapeutics Inc | 5.7M | -0.5x | --- |
Company Information
Titan Pharmaceuticals, Inc. is a pharmaceutical company. The Company is focused on developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. ProNeura offers continuous drug delivery and consists of a small, semi-rigid, flexible implant made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The resulting product is a solid matrix implant that is placed subdermally, normally in the inside part of the upper arm, in a brief procedure using a local anesthetic and is removed in a similar manner at the end of the treatment period. Its product pipeline includes Kappa Opioid Receptor Agonist (TP-2021) Implant, which is used for the treatment of moderate-to-severe chronic pruritus. Its product development programs are in non-clinical stages of development.
Contact Information
- Headquarters
- SUITE 505, 400 OYSTER POINT BLVDSAN FRANCISCO, CA, United States 94080
- Phone
- 415-244-4990
- Fax
- 650-244-4956
Executives
- Chairman of the Board, Chief Executive Officer, Principal Financial Officer
- Gim Shen Seow
- Director
- Brynner Chiam
- Independent Director
- Avraham Ben-Tzvi
- Independent Director
- Firdauz Edmin Bin Mokhtar
- Independent Director
- Francisco Garcia
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.8M |
|---|---|
Revenue (TTM) | $4.0K |
Shares Outstanding | 914.2K |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.09 |
EPS | $-6.59 |
Book Value | $8.50 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | 1,197.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -178,225.00% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
